Oncolytics Biotech Inc. - Common Shares (ONCY) earnings
Quarterly and annual ONCY reports and results, each read against the price at its own news timestamp. Back to the ONCY overview →
7 measured ONCY earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ONCOLYTICS BIOTECH INC For: Jun 30 | SEC filing · Form 10-Q | -3.56% | -4.76% | |
| Form 10-Q ONCOLYTICS BIOTECH INC For: Mar 31 | SEC filing · Form 10-Q | -2.30% | -2.30% | |
| Form 10-K ONCOLYTICS BIOTECH INC For: Dec 31 | SEC filing · Form 10-K | +5.88% | +4.79% | |
| Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights | Press release | +1.82% | +4.67% | |
| Oncolytics Biotech® Reports Second Quarter 2024 Financial Results and Operational Highlights | Press release | -1.93% | -0.97% | |
| Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights | Press release | +0.00% | -5.64% | |
| Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights | Press release | -3.07% | -3.91% |
Keep exploring
More ONCY: analyst actions → · SEC filings → · ONCY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BIOSTAGE INC NEW (BSTG) | 532 | 0.00% | 22% |
| OBALON THERAPEUTICS (OBLN) | 532 | -0.09% | 42% |
| Dr. Reddy's Laboratories Ltd (RDY) | 528 | 0.00% | 47% |
| LOXO ONCOLOGY (LOXO) | 526 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.